Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 2
2017 2
2018 3
2019 2
2020 5
2021 7
2022 9
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Expert opinion on emerging drugs for lung chronic graft-versus-host disease.
Gabrielli G, Dogliotti I, Mangiapia M, Chiappero C, Gill J, Dellacasa CM, Busca A, Giaccone L. Gabrielli G, et al. Among authors: dogliotti i. Expert Opin Emerg Drugs. 2022 Jun;27(2):99-101. doi: 10.1080/14728214.2022.2089651. Epub 2022 Jun 22. Expert Opin Emerg Drugs. 2022. PMID: 35733295 No abstract available.
Diagnostics in Waldenström's macroglobulinemia: a consensus statement of the European Consortium for Waldenström's Macroglobulinemia.
Dogliotti I, Jiménez C, Varettoni M, Talaulikar D, Bagratuni T, Ferrante M, Pérez J, Drandi D, Puig N, Gilestro M, García-Álvarez M, Owen R, Jurczak W, Tedeschi A, Leblond V, Kastritis E, Kersten MJ, D'Sa S, Kaščák M, Willenbacher W, Roccaro AM, Poulain S, Morel P, Kyriakou C, Fend F, Vos JMI, Dimopoulos MA, Buske C, Ferrero S, García-Sanz R. Dogliotti I, et al. Leukemia. 2023 Feb;37(2):388-395. doi: 10.1038/s41375-022-01762-3. Epub 2022 Nov 26. Leukemia. 2023. PMID: 36435884 Free PMC article.
Update on emerging treatments for chronic myeloid leukemia.
Fava C, Morotti A, Dogliotti I, Saglio G, Rege-Cambrin G. Fava C, et al. Among authors: dogliotti i. Expert Opin Emerg Drugs. 2015 Jun;20(2):183-96. doi: 10.1517/14728214.2015.1031217. Epub 2015 Mar 31. Expert Opin Emerg Drugs. 2015. PMID: 25826695 Review.
Efficacy of rituximab in anti-myelin-associated glycoprotein demyelinating polyneuropathy: Clinical, hematological and neurophysiological correlations during 2 years of follow-up.
Parisi M, Dogliotti I, Clerico M, Bertuzzo D, Benevolo G, Orsucci L, Schiavetti I, Cavallo R, Cavallo F, Ragaini S, Di Liberto A, Ferrante M, Bondielli G, Artusi CA, Drandi D, Lopiano L, Ferrero B, Ferrero S. Parisi M, et al. Among authors: dogliotti i. Eur J Neurol. 2022 Dec;29(12):3611-3622. doi: 10.1111/ene.15553. Epub 2022 Sep 25. Eur J Neurol. 2022. PMID: 36083713 Free PMC article.
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Gotti M, Sciarra R, Pulsoni A, Merli F, Luminari S, Zerbi C, Trentin L, Re A, Rusconi C, Viviani S, Rossi A, Cocito F, Botto B, Meli E, Pinto A, Dogliotti I, Gini G, Puccini B, Ricci F, Nassi L, Fabbri A, Liberati AM, Merli M, Filippi AR, Bonfichi M, Zoboli V, Tartaglia G, Annechini G, D'Elia GM, Del Giudice I, Alvarez I, Visentin A, Pravato S, Dalceggio D, Pagani C, Ferrari S, Cristinelli C, Lazic T, Ferretti VV, Ricardi U, Arcaini L. Gotti M, et al. Among authors: dogliotti i. Hemasphere. 2023 Apr 4;7(4):e837. doi: 10.1097/HS9.0000000000000837. eCollection 2023 Apr. Hemasphere. 2023. PMID: 37034003 Free PMC article.
SARS-CoV-2 infection in a stem cell transplant recipient grafted from a SARS-CoV-2-positive donor.
Busca A, Gabrielli G, Sidoti F, Costa C, Giaccone L, Dogliotti I, Dellacasa CM, Francisci T, Pecoraro C, Ruggeri M, Cavallo R, De Rosa F. Busca A, et al. Among authors: dogliotti i. Bone Marrow Transplant. 2022 Oct;57(10):1604-1606. doi: 10.1038/s41409-022-01763-x. Epub 2022 Jul 16. Bone Marrow Transplant. 2022. PMID: 35842475 Free PMC article. No abstract available.
33 results